PolicyWinds
Topic and direction labels are AI-assisted, and each one quotes the bill text it is based on. How labels work
New York · 2025-2026 General Assembly

A09217 Provides that the prescribing, dispensing, or receipt of mifepristone or any drug used for medication abortion shall not be considered a criminal conversion act under certain circumstances; provides that mifepristone or any drug used for medication abortion shall not be deemed to be adulterated or misbranded under certain circumstances.

Direction

Abortion medication abortionAI label

Expands abortion access model confidence 95%

Protects the prescribing, dispensing, and receipt of mifepristone or other medication abortion drugs from being treated as criminal diversion or misbranding under state law even if no longer FDA-approved or bearing current labeling, provided labeling was accurate at manufacture and use follows WHO,

The prescribing, dispensing, or receipt of brand name or generic mifepristone or any drug used for medication abortion shall not be considered a criminal diversion act for purposes of this definition solely because it is no longer approved by the federal food and drug administration or because it no longer bears the label currently in effect, provided that: (i) its labeling was true and accurate at the time of manufacture; and (ii) the drug is recommended for the purpose for which it was prescribed under World Health Organization guidelines that are current at the time of prescribing or

✓ Quote verified word for word in the bill text

  1. Filed (completed)
  2. Committee
  3. Passed one chamber
  4. Passed both
  5. Governor
  6. Law

Status: Died (session ended)

Last action
2026-01-28: substituted by s8544
Filed
2025-11-03
Sponsor
Amy Paulin D + 8 cosponsors (8 D)

Why the model tagged it this way: The bill amends penal and education law to exclude mifepristone and other medication abortion drugs from state criminal diversion and misbranding prohibitions when they deviate from current FDA approval or labeling, if they meet specified conditions tied to original accuracy and WHO guidelines. This shields medication abortion access from certain state enforcement actions that would otherwise apply.

Related bills

Hearings and calendar

Votes

DateChamberMotionYea-Nay
2026-01-21AAssembly Codes Committee: Favorable13-5Passed

Sponsors

Text versions

History (5 actions)
DateChamberAction
2026-01-28Asubstituted by s8544
2026-01-22Aadvanced to third reading cal.241
2026-01-21Areported
2026-01-07Areferred to codes
2025-11-03Areferred to codes